Table 2.
Tocolytic Regimen |
n | Median (IQR) Gestational Age at Presentation (weeks) |
Median (IQR) Cervical Dilation at Presentation (cm) |
Median (IQR) Gestational Age at Delivery (weeks) |
Latency of >= 48 hours (n, %) |
Major neonatal morbidity (n, %) |
---|---|---|---|---|---|---|
No tocolysis | 64 | 29.8 (27.6 – 31.1) |
6 (4.5 – 6.5) |
29.9 (27.9 – 31.2) |
5 (7.8) | 28 (43.8) |
Any one tocolytic* | 123 | 29.4 (27.6 – 31.1) |
5 (4 – 6)† |
29.9 (26.4 – 31.1) |
24 (19.5)* |
51 (41.5) |
Any two tocolytics* | 88 | 28.0 (25.6 – 30.4)* |
4.5 (4 – 5)† |
28.9 (26.1 – 31.7) |
25 (28.4)† |
40 (45.5) |
Three tocolytics* | 22 | 28.7 (26.5 – 30.4) |
4 (4 – 5)† |
29.0 (26.7 – 31.7) |
6 (27.3)† | 6 (27.3) |
p-value | 0.087 | <0.001 | 0.566 | 0.014 | 0.482 |
Studied tocolytics: indomethacin, magnesium sulfate, nifedipine.
indicates p<0.05 in pairwise comparison with ‘no tocolysis’ group as referent.